Belgian pharma company UCB has signed a global exclusive license deal worth up to $2 billion for its Alzheimer’s Disease drug candidate (AD drug candidate) UCB0107 with Roche and its subsidiary Genentech. UCB0107 is a monoclonal antibody drug candidate, which is being developed by UCB as a potential therapy for patients with progressive supranuclear palsy […]
French insurance giant AXA has signed a €620 million deal to sell AXA Bank Belgium, its Belgian banking operations, to Crelan Bank, a Belgium-based cooperative bank. The sale of AXA Bank Belgium is another major step taken by AXA in the execution of its Ambition 2020 strategy. The French insurer is looking to focus on […]
TransPerfect, a provider of language and technology solutions, has acquired Lylo Media Group, a Belgium-based provider of dubbing, voiceover, audio description, subtitling, and hard-of-hearing services, for an undisclosed price. Established in 2012 in Brussels, Lylo Media Group is said to have built a strong footprint across Europe. The company has studios in France, Belgium, Italy, […]
Oil and gas industry news : Fluxys and Snam will buy out the 33.5% stake of Canadian pension fund Caisse de depot et placement du Quebec (CDPQ) in the Interconnector UK pipeline in the southern North Sea for about $103 million. Through the transaction, the Belgian natural gas transmission system operator Fluxys and the Italian […]
French pharmaceutical giant Sanofi has successfully finalized an agreement to acquire Ablynx, a Belgian biotechnology firm, for approximately €3.9 billion. This strategic acquisition surpasses a previous offer of €2.6 billion from Danish pharmaceutical company Novo Nordisk, which Ablynx had rejected citing undervaluation. Details of the Acquisition Ablynx, based in Ghent and established in 2001 as […]
Japanese pharmaceutical giant Takeda Pharmaceutical has announced a proposal to acquire TiGenix, a Belgium-based cell therapy company, for €520 million. This acquisition is aimed at expanding Takeda’s late-stage gastroenterology portfolio and enhancing its presence in the American specialty care market. TiGenix, established in 2000, specializes in the development of novel treatments for serious medical conditions […]